HYUNDAI BIOLAND Co.,Ltd.

₩3,590As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:052260Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (7.91%)
Div yield 1.95%
ROE 9.53%
Pharmaceutical Preparations
Beta (5Y) 0.82
PE TTM 8.079
TSR TTM (17.68%)
Mkt cap ₩107.7B
ROIC 9.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,115
14.62%
(46.31%)
Hold 3|1|7|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
82.74
86.74
92.13
101.70
10.08%
9.95%
5.25%
21.31%
Revenue₩B
6.425
6.374
6.209
6.524
7.21%
3.96%
(2.59%)
2.96%
Peers (US$79.40M)
Cap (US$)
PE
68.91M
7.871x
Capital
TTM
5Y
10Y
Leveragex
0.562
(0.307)
(0.272)
EBIT/Intx
1.020
0.229
0.210
Own earn%
10.83
(70.62)
(75.33)
Sh yield%
31.96
41.17
39.28
Owners
Insiders/Inst%
4.37
83.21
Short interest%
1.36
SBC / revenue%
3.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
14–21
$1 testx
—
Incr. ROIC%
10